These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28182126)

  • 21. Silencing of the metastasis-linked gene, AEG-1, using siRNA-loaded cholamine surface-modified gelatin nanoparticles in the breast carcinoma cell line MCF-7.
    Abozeid SM; Hathout RM; Abou-Aisha K
    Colloids Surf B Biointerfaces; 2016 Sep; 145():607-616. PubMed ID: 27285732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and characterization of gelatin nanoparticles using CDI/NHS as a non-toxic cross-linking system.
    Qazvini NT; Zinatloo S
    J Mater Sci Mater Med; 2011 Jan; 22(1):63-9. PubMed ID: 21052793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research.
    Elzoghby AO
    J Control Release; 2013 Dec; 172(3):1075-91. PubMed ID: 24096021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune response to antituberculosis drug-loaded gelatin and polyisobutyl-cyanoacrylate nanoparticles in macrophages.
    Sarfraz M; Shi W; Gao Y; Clas SD; Roa W; Bou-Chacra N; Löbenberg R
    Ther Deliv; 2016; 7(4):213-28. PubMed ID: 27010984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advancement of gelatin nanoparticles in drug and vaccine delivery.
    Sahoo N; Sahoo RK; Biswas N; Guha A; Kuotsu K
    Int J Biol Macromol; 2015 Nov; 81():317-31. PubMed ID: 26277745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of albumin-based nanoparticles for the delivery of abacavir.
    Wilson B; Paladugu L; Priyadarshini SR; Jenita JJ
    Int J Biol Macromol; 2015 Nov; 81():763-7. PubMed ID: 26365020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gelatin nanoparticles for NSAID systemic administration: Quality by design and artificial neural networks implementation.
    Koletti AE; Tsarouchi E; Kapourani A; Kontogiannopoulos KN; Assimopoulou AN; Barmpalexis P
    Int J Pharm; 2020 Mar; 578():119118. PubMed ID: 32032642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and characterization of folate decorated albumin bio-conjugate nanoparticles loaded with a synthetic curcumin difluorinated analogue.
    Gawde KA; Kesharwani P; Sau S; Sarkar FH; Padhye S; Kashaw SK; Iyer AK
    J Colloid Interface Sci; 2017 Jun; 496():290-299. PubMed ID: 28236692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and characterization of hydrogel nanoparticles with tunable network characteristics for sustained release of a VEGF-mimetic peptide.
    Young DA; Pimentel MB; Lima LD; Custodio AF; Lo WC; Chen SC; Teymour F; Papavasiliou G
    Biomater Sci; 2017 Sep; 5(10):2079-2092. PubMed ID: 28744527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery.
    Tam YT; To KK; Chow AH
    Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gelatin-encapsulated iron oxide nanoparticles for platinum (IV) prodrug delivery, enzyme-stimulated release and MRI.
    Cheng Z; Dai Y; Kang X; Li C; Huang S; Lian H; Hou Z; Ma P; Lin J
    Biomaterials; 2014 Aug; 35(24):6359-68. PubMed ID: 24816364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B.
    Jain S; Valvi PU; Swarnakar NK; Thanki K
    Mol Pharm; 2012 Sep; 9(9):2542-53. PubMed ID: 22845020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of alkyl chain length of monothiol-terminated alkyl carboxylic acid in the synthesis, characterization, and application of gelatin-g-poly(N-isopropylacrylamide) carriers for antiglaucoma drug delivery.
    Luo LJ; Lai JY
    Acta Biomater; 2017 Feb; 49():344-357. PubMed ID: 27890728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and evaluation of clickable gelatin-oleic nanoparticles using fattigation-platform for cancer therapy.
    Meghani NM; Amin HH; Park C; Park JB; Cui JH; Cao QR; Lee BJ
    Int J Pharm; 2018 Jul; 545(1-2):101-112. PubMed ID: 29698822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis.
    Saraogi GK; Sharma B; Joshi B; Gupta P; Gupta UD; Jain NK; Agrawal GP
    J Drug Target; 2011 Apr; 19(3):219-27. PubMed ID: 20540651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery.
    Jain SK; Gupta Y; Jain A; Saxena AR; Khare P; Jain A
    Nanomedicine; 2008 Mar; 4(1):41-8. PubMed ID: 18207463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gelatin Nanoparticles.
    Hathout RM; Metwally AA
    Methods Mol Biol; 2019; 2000():71-78. PubMed ID: 31148009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transglutaminase: new insights into gelatin nanoparticle cross-linking.
    Fuchs S; Kutscher M; Hertel T; Winter G; Pietzsch M; Coester C
    J Microencapsul; 2010; 27(8):747-54. PubMed ID: 21034367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Bovine Lactoferrin Nanoparticle Prepared by Desolvation Technique.
    Taguchi K; Chuang VTG; Hashimoto M; Nakayama M; Sakuragi M; Enoki Y; Nishi K; Matsumoto K; Seo H; Otagiri M; Yamasaki K
    Chem Pharm Bull (Tokyo); 2020; 68(8):766-772. PubMed ID: 32741918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.